These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14667221)

  • 1. Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design.
    Zauhar RJ; Moyna G; Tian L; Li Z; Welsh WJ
    J Med Chem; 2003 Dec; 46(26):5674-90. PubMed ID: 14667221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FURSMASA: a new approach to rapid scoring functions that uses a MD-averaged potential energy grid and a solvent-accessible surface area term with parameters GA fit to experimental data.
    Pearlman DA; Rao BG; Charifson P
    Proteins; 2008 May; 71(3):1519-38. PubMed ID: 18300249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of ligands for the serotonin receptor using the Shape Signatures approach.
    Nagarajan K; Zauhar R; Welsh WJ
    J Chem Inf Model; 2005; 45(1):49-57. PubMed ID: 15667128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLEXS: a method for fast flexible ligand superposition.
    Lemmen C; Lengauer T; Klebe G
    J Med Chem; 1998 Nov; 41(23):4502-20. PubMed ID: 9804690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
    Moon JB; Howe WJ
    Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.
    Perryman AL; Lin JH; Andrew McCammon J
    Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based ligand design by dynamically assembling molecular building blocks at binding site.
    Liu H; Duan Z; Luo Q; Shi Y
    Proteins; 1999 Sep; 36(4):462-70. PubMed ID: 10450088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring.
    Sastry GM; Dixon SL; Sherman W
    J Chem Inf Model; 2011 Oct; 51(10):2455-66. PubMed ID: 21870862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.
    Reid RC; Pattenden LK; Tyndall JD; Martin JL; Walsh T; Fairlie DP
    J Med Chem; 2004 Mar; 47(7):1641-51. PubMed ID: 15027855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape Signatures: speeding up computer aided drug discovery.
    Meek PJ; Liu Z; Tian L; Wang CY; Welsh WJ; Zauhar RJ
    Drug Discov Today; 2006 Oct; 11(19-20):895-904. PubMed ID: 16997139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural parameterization of the binding enthalpy of small ligands.
    Luque I; Freire E
    Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive docking study on the selectivity of binding of aromatic compounds to proteins.
    Hetényi C; Maran U; Karelson M
    J Chem Inf Comput Sci; 2003; 43(5):1576-83. PubMed ID: 14502492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer design of bioactive compounds based on 3-D properties of ligands.
    Martin YC
    NIDA Res Monogr; 1993; 134():84-102. PubMed ID: 8289889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SitePrint: three-dimensional pharmacophore descriptors derived from protein binding sites for family based active site analysis, classification, and drug design.
    Arnold JR; Burdick KW; Pegg SC; Toba S; Lamb ML; Kuntz ID
    J Chem Inf Comput Sci; 2004; 44(6):2190-8. PubMed ID: 15554689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.